Clinical Trial Update: Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing humoral and cellular immune responses to a Japanese Encephalitis vaccine in elderly participants, with the study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Japanese Encephalitis Vaccine (Japanese Encephalitis vaccine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Humoral and Cellular Immune Responses | Phase 4 | Status: COMPLETED